|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3D QSAR (1) | 3D-QSAR (1) |
| 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) |
| 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
| 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) |
| 6 (1) | 6-beta naltrexol (1) | 6-Mercaptopurine (1) |
| 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) | 7 (1) |
| 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | 99mTc-ciprofloxacin (1) |
| A. nilotica (1) | ABC analysis (5) | ABC-VED matrix (4) |
| ABC-VEN analysis (1) | Abdominal Pregnancy (1) | Abheshaja (1) |
| Absorbance ratio (1) | Absorption ratio (1) | ABTS (1) |
| Abuse (1) | Academic Stressors scale (1) | Accuracy. (1) |
| Accurate (1) | ACE (2) | ACE inhibitor (1) |
| Aceclofenac (1) | ACEIs (1) | Acetaminophen (1) |
| Acetazolamide (1) | Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) |
| Acetyl cholinesterase estimation (1) | Acetyl isoniazid (1) | Acetylation rate (1) |
| Acetylcholinesterase (1) | Acetylcholinesterase inhibitors (1) | ACF (1) |
| Acid hydrolysis (1) | Acid violet 43 (1) | Acid-resistant capsules (1) |
| Acne (2) | Acne vulgaris (1) | Aconitine (1) |
| Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Act score (1) |
| Actinomycetes (1) | Activator procaspase-3 (1) | active pharmaceutical ingredient (1) |
| Active site (1) | Activities of daily living (ADL) scale (1) | Activity domain (1) |
| Acupuncture (1) | Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) |
| Acute Inflammation (1) | Acute inß ammation (1) | Acute Kidney Damage (1) |
| Acute poisoning (1) | Acute Side Effects (1) | Acute ST segment elevation myocardial infarction (1) |
| Acute toxicity (1) | acyclovir (2) | ADE (1) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
| Adherence. (1) | Adiantum venustum (1) | Adjuvant therapy (1) |
| ADME properties. (1) | Adnexal masses (1) | ADR (2) |
| ADR (Adverse Drug Reaction) (2) | ADR management (1) | ADR monitoring centre (AMC). (1) |
| ADR reporting (1) | ADR(Adverse Drug Reaction) (1) | ADRs (2) |
| Adsorbent (1) | Adverse drug event (1) | adverse drug events (1) |
| Adverse drug reaction (12) | Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) |
| Adverse drug reaction. (1) | Adverse Drug Reactions (9) | Adverse drug reactions (ADRs) (1) |
| Adverse event following immunization (AEFI) (1) | Adverse events (2) | Adverse reaction (1) |
| Aedes aegypti (2) | Aerobic exercise (1) | Aerosil (1) |
| affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (2) | Ageratum conyzoides L (1) |
| Agrobacterium (1) | air pollution (1) | Airjet (1) |
| Albendazole (1) | Albino mice (1) | Albino wistar rats (1) |
| Alcohol (2) | Alcohol withdrawl seizure (1) | alcoholic extract (1) |
| ALDEN (1) | Aldose reductase inhibitors (1) | Alkaloids (1) |
| allantoin (1) | Allergic rhinitis (1) | Allergy (4) |
| Allium sativum (1) | Alloxan (1) | Alloxan monohydrate (1) |
| Alocasia indica Schott (1) | Aloe vera (1) | Alpha mangostin (1) |
| Alpha-adrenoceptor (1) | alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) |
| Alprazolam (1) | Alteration of drug cost (1) | Altered Mental Status (AMS) (1) |
| alternative therapy (1) | Alzheimer's disease (1) | Alzheimers disease (1) |
| Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) | Amber (1) |
| Ambroxol hydrochloride (1) | Ambulatorial Surgery Procedures (1) | Amides (1) |
| Amikacin Sulfate (1) | Amino acids (1) | amino benzylated Mannich bases (1) |
| amivudine (1) | Amlodipine (2) | Amlodipine besylate (2) |
| Ammonium salts (1) | Amoora cucullata. (1) | amoxicillin (1) |
| Amoxicillin sodium (1) | Anabolic steroids (1) | Anabolic. (1) |
| Anaemia (2) | Analgesia (1) | analgesic (8) |
| Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) | Analgesics (1) |
| Analysis in capsules (1) | Analysis of variance (1) | Anaphylactic shock (1) |
| Anaphylaxis. (1) | and TGF–β (1) | Andragogy (1) |
| Anemia (2) | Anethum graveolens (1) | Angiogenesis (1) |
| Angiogenic growth factors (1) | Angiotensin Converting Enzyme Inhibitors (1) | Animal model (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthocyanin (1) | Anthracyclines (2) | Anti aging (1) |
| Anti hyperglycemic (1) | Anti inflammatory (1) | anti-anxiety activity (1) |
| Anti-asthmatic activity (1) | Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) |
| Anti-diabetic drugs (1) | Anti-epileptic drugs utilization (1) | Anti-HIV (1) |
| anti-hypertensive agent (1) | Anti-infective (2) | Anti-infective agents (1) |
| anti-inflammation (1) | anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) |
| anti-inflammatory activity (2) | anti-inflammatory activity', (1) | anti-inflammatory agent (1) |
| anti-inß ammatory (3) | Anti-inß ammatory activity (1) | Anti-obesity (1) |
| Anti-oxidant (2) | Anti-parkinsonism activity (1) | anti-spasmodic drug (1) |
| Anti-TB drugs (1) | Anti-tumor agent (1) | antiamnesic agents (1) |
| Antianxiety (1) | antibacterial (3) | antibacterial activity (4) |
| Antibacterial drugs (1) | Antibiotic (2) | antibiotic guidelines (1) |
| Antibiotic Resistance (2) | Antibiotics (4) | Antibiotics. (1) |
| Anticancer (5) | Anticancer activity (1) | Anticancer drugs (1) |
| Anticholinergic (1) | Anticoagulant (2) | Anticoagulant service (1) |
| anticonvulsant (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (1) |
| Antidiabetic (3) | Antidiabetic activity (2) | Antidiabetic agents (1) |
| antiepileptic agents (1) | Antiepileptic Drugs (3) | antifungal (1) |
| antifungal activity (1) | Antigen (1) | antigen protein (1) |
| Antiglycation (1) | Antihistaminic (2) | Antihyperglycemic (1) |
| Antihypertensive (1) | Antihypertensives (1) | Antiinflamatory (1) |
| Antimalarial (2) | Antimicrobial (4) | Antimicrobial activities (1) |
| Antimicrobial activity (6) | Antimicrobial agent (1) | Antimicrobial efficacy (1) |
| Antimicrobial resistance (2) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) | Antimicrobial Stewardship (1) |
| Antimicrobials (4) | Antimosquito (1) | Antimycotic Activity (1) |
| antinociceptive (1) | Antioxidant (19) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) |
| Antioxidant activity (7) | antioxidant effect (1) | Antioxidant properties (1) |
| Antioxidants (6) | Antipsychotics (1) | antipyretic (2) |
| Antiretroviral drugs (1) | Antiretroviral therapy (2) | Antispasmodic (1) |
| Antithrombotic (2) | Antithyroid drugs (1) | Antitubercular (1) |
| Antitubercular drugs. (1) | antiulcer (1) | Antivenom (1) |
| Antivenom reactions (1) | Antiviral (2) | antiviral activity (1) |
| Antiviral RNA (1) | Anxiety (4) | Anxiolytics (1) |
| APAP (1) | APC (1) | Apoptosis (2) |
| Application (1) | Application to PK profile studies (1) | applications (1) |
| Appropriateness (1) | Aqueous extract (3) | AR Caps (1) |
| Arabic gum (1) | ARBs (1) | ARDS (1) |
| Area above the blood glucose levels-time curve. (1) | area of wound healing (1) | Areca nut (1) |
| Arginase (2) | Arginine (1) | Armodafinil (1) |
| ART (1) | Artemia salina (1) | Artemia salina. (1) |
| Artemisia (1) | Artemisia absinthium (1) | Artemisia macrocephala (1) |
| arterial hypertension (1) | Arterial stiffness (1) | Arteriovenous malformation (AVM) (1) |
| Arthritis (1) | ARV Drugs (1) | Ascorbic acid (3) |
| Asenapine (1) | asian developing nations (1) | Asiaticoside (1) |
| Asparagus racemosus root extract (1) | Aspergillus niger (2) | Aspergillus niger. (1) |
| Aspergillus terreus (1) | Aspirin (1) | Assay (2) |
| Asthma (6) | Asymptomatic neurocognitive impairment (1) | Ataxia (3) |
| ATC/DDD (3) | Atenolol (1) | Atherosclerosis (1) |
| Atherosclerotic Vascular Disease (1) | Athlete Biological Passport (1) | Atorvastatin (5) |
| Atorvastatin calcium (1) | Atorvastatin. (1) | ATP synthase inhibitor (1) |
| ATP- sensitive K+channel (1) | Atractylis flava Desf (1) | Atrial fibrillation (1) |
| Atropine (1) | Attitude (6) | Attitude and practice (1) |
| Attitude. (1) | Atypical antipsychotics (1) | Aucubin (1) |
| Authors (1) | Authorship issues (1) | Autism spectrum disorders (1) |
| Auto antibody (1) | Auto medication (1) | Autoimmune disorders (1) |
| Autoimmunity (1) | Averrhoa bilimbi (1) | Avicel (1) |
| Awareness (3) | Ayurveda (2) | Ayurvedic (1) |
| Azelaic acid (1) | Azilsartan medoxomil (1) | B cell epitope (1) |
| Bacoside A3 (1) | Bacteremia (1) | Bacterial isolates (1) |
| Bacteriological culture (1) | Bacteriostatic (1) | Bamboo betung (1) |
| Banana (1) | Bangladesh (2) | bark (1) |
| Barleria cristata (1) | Barriers (1) | Bauhinia racemosa (1) |
| Bauhinia variegata (2) | Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) |
| BCG vaccine (1) | BCS-IV drug (1) | Beauty Salon Owner (1) |
| Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) | Bedaquiline (1) |
| Behavioral research (1) | Belief (1) | Benchmarking (1) |
| Benzimidazole derivative (1) | benzimidazoles (2) | Benzodiazepines (1) |
| Benzothiazole analogues (1) | Berberis integerrima Bunge (1) | Beta-lactamase (1) |
| Beta-lactamic (1) | Bibliometrics (4) | Bioactive Metabolites (2) |
| Bioadhesive (1) | Bioanalytical (1) | Bioanalytical method (2) |
| Bioanalytical method development (1) | Bioassay (1) | bioavailability (5) |
| Biodegradable (1) | Bioethics (1) | Biofilm (1) |
| Biohazard (1) | Biologics (1) | Biology (1) |
| Biomedical (1) | Bioprospecting. (1) | Biopsy Proven Acute Rejection (1) |
| Biosafety (1) | Biosafety Engineering Control (1) | Biosimilars (1) |
| Biotechnology (2) | Bisphosphonates (1) | Bitter (1) |
| Black tea extract (1) | BLAST (1) | Bleaching (1) |
| Bleeding time (1) | Bleomycin (1) | Blonanserin (1) |
| Blood brain barrier (1) | Blood glucose (1) | Blood pressure (4) |
| Body Mass Index (1) | Body Mass Index (BMI). (1) | Boerhaavia Diffusa (1) |
| Bone (2) | Book Review (1) | Borg scale (1) |
| botulinum toxin (1) | Box-Behnken (1) | Brahmi vati (1) |
| Brain (1) | Brand Drugs (1) | brand name drugs (1) |
| Branded medication (1) | Bratton-Marshall reagent (1) | Brazil (1) |
| Breast cancer (6) | Brewer’s yeast (1) | Brief COPE scale (1) |
| Brief medication questionnaire (1) | Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) |
| Brine-shrimp lethality. (1) | Bromelain (1) | Bromeliaceae (1) |
| Bromocresol purple (1) | Bronchial Asthma (2) | Bryonia laciniosa (1) |
| Buccal (1) | Buccal Patches (1) | budget forecasting (1) |
| Bufadienolide (1) | Bullous eruption (1) | bungarotoxin (1) |
| Bungarus caeruleus (1) | Bungur (1) | Buni-berry extract (1) |
| Buoyancy (1) | Buoyant microspheres (1) | Burden Of Disease (1) |
| Business method (1) | Business model (1) | Butea monosperma (1) |
| C-reactive protein (1) | C934 (1) | CA125 (1) |
| Ca2+ channels (1) | Cadmium chloride (1) | Caesalpinia decapetala (1) |
| Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) | Caesalpinia sappan (1) |
| CAGR (1) | Calcineurin inhibitor (1) | Calcium (1) |
| Calcium channel blocking (1) | calcium channel blocking activity (1) | Calcium oxalate (1) |
| Calcium silicate (1) | Calendula officinalis (1) | calendula oil (1) |
| CAM Assay (1) | Camelia sinensis extract (1) | Camellia sinensis (1) |
| Camptothecin (1) | Cancer (7) | Cancer Chemotherapy (2) |
| Cancer treatment (1) | Candida (2) | Candida albicans (3) |
| Candida albicans. (1) | Capacity (1) | Capsule (1) |
| capsules (1) | carbamazepin (1) | Carbamazepine (2) |
| carbohydrazide (1) | Carbomyl Linkage (1) | carbon tetrachloride (1) |
| carbonyl compounds (1) | Carbopol 940 (1) | Carcinoma. (1) |
| cardiac arrhythmias (1) | Cardiac remodeling (1) | Cardiology (1) |
| Cardioprotection (1) | Cardioprotective (1) | Cardiotoxicity (2) |
| Cardiovascular disease (1) | Cardiovascular drugs (1) | Career Choices (1) |
| Carica papaya L. (1) | Caries Activity (1) | Carnauba wax (1) |
| carrageenan (2) | Caryocar coriaceum (1) | Case report (1) |
| Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) | Catalase (1) |
| catalepsy (2) | Cation-pi (1) | CationicGuargum (1) |
| Causality assessment (2) | Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) |
| CD150 (1) | CD244.2 (1) | CD48 (1) |
| Cefixime (1) | Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) |
| Cefuroxime (1) | Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) |
| Cellulase (1) | Cellulite (1) | Cellulitis (1) |
| Cellulose (2) | Cemented (1) | Cementless (1) |
| CEN (1) | Centella asiatica (3) | Central composite design (4) |
| Central post-stroke pain (1) | Cephalexin (2) | Cerebrovascular Accident (1) |
| Cervical bulge (1) | Cervical dentine hypersensitivity (1) | CFFF (1) |
| chalcone (1) | chalcones (1) | Challenges (1) |
| Chamomile tea (1) | Characterization (4) | Chebulinic acid (1) |
| Chemical stability (1) | Chemiluminescence (1) | Chemomechanical removal (1) |
| Chemometrics (2) | Chemotaxis (1) | Chemotherapy (6) |
| Chewing gum (1) | Child Care (1) | Children (2) |
| Children Dentistry (1) | Chitin (1) | Chitosan (6) |
| Chitosan Acetate. (1) | chitosan microspheres (1) | Chitosan nanoparticle (1) |
| Chitosan-g-HPβCD (1) | Chlamydomonas reinhardtii (1) | Chloramphenicol (1) |
| Chlorhexidine (2) | Chlorohexidine (1) | cholesterol (1) |
| Cholesterol HDL (1) | Cholinesterase inhibitors (1) | Chromotropic acid reagent (1) |
| Chronic hepatitis B (1) | Chronic kidney disease (2) | Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) |
| Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) | Cigarette smoke (1) |
| Cilostazol (1) | Cinnamaldehyde (1) | Cinnamic acid derivatives (1) |
| Cinnamomum cassia (1) | Ciprofloxacin (1) | Citronella (1) |
| Citrus hystrix (1) | Citrus limon (2) | CKD (1) |
| CKMB. (1) | Claims (1) | Clarithromycin (1) |
| Classification (1) | Clastogenicity (1) | Cleistanthin A (2) |
| cleistanthin B (2) | Cleistanthus Collinus (1) | Clinical attachment (1) |
| Clinical attachment level (1) | Clinical efficacy (1) | Clinical equivalence (1) |
| Clinical manifestation (1) | Clinical Pharmacist (1) | Clinical pharmacist care (1) |
| Clinical Pharmacists (1) | Clinical pharmacology (1) | Clinical Pharmacy Services (1) |
| Clinical research (1) | Clinical trial (1) | Clinical trials (1) |
| Clinicians (1) | clonidine (2) | Clopidogrel (1) |
| Closed melt (1) | Clove (1) | cloxacillin (1) |
| Cluster analysis (1) | CME (1) | CNS stimulants (1) |
| Co-crystal (1) | Co-Morbidity (1) | Co-morbidity. Correspondence (1) |
| co-precipitation method (1) | Co-surfactant (1) | Cochlopermum tinctorium (1) |
| coding system (1) | Cognition (2) | Cognitive impairment (1) |
| Cogrinding (1) | Colloidal carriers (1) | Colloidal silicone dioxide (1) |
| Colon targeted delivery (1) | Colon targeted drug delivery. (1) | Colon targeting (1) |
| Colonic delivery (1) | colorimetric assay (1) | Combination tablet (1) |
| Combination Therapy (1) | Combinatorial effect (1) | Comet assay (1) |
| common cold (1) | common cold and cough (1) | Common warts (1) |
| Community Pharmacies (2) | Community pharmacist (3) | Community Pharmacists (2) |
| Community pharmacy (2) | Community Pharmacy Patient Questionnaire (1) | Comorbidity (1) |
| Comparative dissolution (1) | comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) |
| compensation (1) | Complementary and alternative medicine (2) | complementary and alternative medicines (1) |
| Complementary and alternative therapy (1) | complete epithelization (1) | Complexation (1) |
| Compliance (1) | compound 48/80 (2) | compritol 888 ATO (1) |
| Computer (1) | Computer literacy (1) | computer-aided instructions (1) |
| Computer-aided learning (1) | Computerized screening systems (1) | CoMSIA (1) |
| Conessine (1) | Constipation (1) | Consumer (1) |
| Consumer perception (1) | Consumer’s Perception (1) | Content validation (1) |
| content validity (1) | continuing education (1) | Continuous Pharmacy Education. (1) |
| Contract research (1) | Contract research organizations (1) | Control (1) |
| Controlled release (4) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Coprocessed excipient (1) |
| Cordia obliqua (1) | Corneal opacities (1) | Coronally advanced flap (1) |
| Correlation (2) | Corticosteroid (2) | Corticosteroids (2) |
| Cosmetic (2) | Cosmetic products (1) | Cosmetics (1) |
| Cosmetics use-related adverse reactions (1) | Cosolvency (1) | Cost avoidance (1) |
| Cost Minimization (1) | Cost of illness (2) | Cost saving (1) |
| Cost-effectiveness analysis (1) | Cost. (1) | Costing Analysis. (1) |
| Cotton dust (1) | Cotton oil (1) | cotton pellet (1) |
| Cough (1) | Cough medicine (1) | cough. (1) |
| Counterfeit Pharmaceutical Products (1) | CPs (1) | Cramer’s Matrix method (1) |
| CRC (1) | Cream (1) | creatinine (1) |
| CRISPR/Cas9 (1) | Critical Care Unit (CCU) (1) | Critical Thinking (1) |
| cromolyn sodium (1) | Cronbach’s alpha (1) | Croscarmellose sodium (CCS) (1) |
| Crospovidone (1) | Crospovidone (CP) (1) | Cross carmellose sodium (1) |
| cross-linking agents (1) | Cross-sectional study (1) | Crossandra (1) |
| Croton zehntneri (2) | Crystallinity (2) | CTCAE (1) |
| CTEPH (1) | Cucumis metuliferus (1) | Cucumis sativus (1) |
| CUMIN. (1) | Cuminosides (1) | Curcuma longa (1) |
| Curcumin (3) | current indian scenario of drug interactions (1) | Curriculum (1) |
| curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) | Cutaneous reaction (1) |
| CXCR4 (1) | Cyclodextrin (1) | Cyclooxygenase (1) |
| cyclophosphamide (1) | Cymbopogon citratus (1) | Cynodon dactylon (2) |
| CYP genes ; South Indian population ; polymorphisms (1) | Cyst (1) | Cytochrome P 2C9 (1) |
| Cytosine (CYS) (1) | Cytotoxic (1) | Cytotoxic activity. (1) |
| Cytotoxic agents (1) | Cytotoxicity (3) | CZE (1) |
| D&C (1) | D-optimal design (1) | Daily Defined Dose (1) |
| Dammam (1) | Dapsone (1) | Data mining algorithms (1) |
| DDX3 (1) | Death Receptors (1) | Decision making (1) |
| Deep vein thrombosis (1) | deferasirox (1) | deferiprone (1) |
| Deficiency (1) | Degradation (1) | Degradation studies (1) |
| Dehydrozingerone (1) | Delignification (1) | Delirium (2) |
| Dementia (1) | democratic government (1) | Dengue (1) |
| Dengue high fever (1) | Dental caries (3) | Dental Caries. (1) |
| Dental implants (1) | dental management (1) | Dental prosthesis. (1) |
| Dental Restoration (1) | Dental Students (1) | Dentistry (2) |
| dentistry. (1) | Dentists (1) | Deodorants (1) |
| Dependence (1) | Depigmentant (1) | Depok Primary Health Care (1) |
| Deprescribing (1) | Depression (3) | Depression 1 (1) |
| Dermatology life Quality Index (1) | Design of experiments. (1) | desirability function (1) |
| Desirability index. (1) | Desmodium gangeticum (1) | Detorsion (1) |
| Deuterium (1) | device safety (1) | dexamethasone (2) |
| Dexibuprofen (1) | Dextrin (1) | Diabetes (6) |
| diabetes and diabetic vascular complications (1) | Diabetes mellitus (13) | diabetes mellitus, (1) |
| Diabetes Type-II (1) | Diabetes, glucose (1) | diabetic dyslipidemia (1) |
| Diabetic nephropathy (1) | Diabetic retinopathy (1) | Diabetic Wound (1) |
| Diacerein (1) | DiaKure (1) | diclofenac (1) |
| Diclofenac SLN (1) | Diclofenac sodium (1) | Dicloxacillin sodium (1) |
| Dicots (1) | Dicyclomine (1) | differential scanning calorimetry (1) |
| diffuse transmittance (1) | Dillenia indica (2) | Dilleniaceae (1) |
| Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) |
| Dip coating (1) | Diplotropis ferruginea (1) | direct compression (3) |
| Direct to consumer advertising (1) | Directly observed treatment short-course (1) | Discharge against medical advice (DAMA) (1) |
| discharge orders (1) | DISCLE (1) | Discrepancies (1) |
| Discriminant analysis (1) | Disease (1) | Disease free survival (1) |
| disintegration (1) | disintegration time (1) | Disproportionality Analysis (1) |
| Dissolution (5) | dissolution enhancement (1) | Dissolution rate (1) |
| Diuretic (1) | Diuretic activity (2) | DMAIC (1) |
| DMH (1) | DNA barcoding (1) | DNA damage (1) |
| DNA fragmentation (1) | docking (4) | docking. (1) |
| Doctor (1) | Documentation (1) | Documentation and records (1) |
| Donepezil hydrochloride (1) | Dopamine (1) | Dosage formulation (1) |
| Dosage regimen (1) | Dose-dependent (1) | DOTS (1) |
| DOTS plus (1) | Doxorubicin (2) | Doxorubicin; FRAP assay (1) |
| Doxycycline (1) | DPP-IV (1) | DPPH Assay (1) |
| DPPH radical scavenging assay (1) | DPPH scavenging (1) | DRcaps (1) |
| DREEM. (1) | Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) |
| droplet size (1) | Drug (2) | Drug allergy tests (1) |
| Drug delivery denture (1) | Drug detailing (1) | drug disposal (2) |
| Drug drug interactions (1) | Drug Hypersensitivity (2) | Drug induced nephrotoxicity (1) |
| Drug Information and Literature Evaluation (1) | drug interaction (2) | Drug interaction (DI) (1) |
| drug interaction management (1) | Drug Interaction probability scale (1) | drug interactions (2) |
| Drug Policies (1) | Drug prescriptions (1) | Drug product (1) |
| Drug Related Problems (4) | Drug related side effects (1) | drug release (1) |
| Drug Resistance (3) | Drug risk ratio (1) | Drug safety (2) |
| Drug Safety. (1) | Drug therapy (1) | Drug utilization (3) |
| drug utilization study (1) | Drug utilization. (1) | drug-drug interactions (4) |
| Drug-related problem (2) | Drug-SLS tablets. (1) | Drugedrug interaction (1) |
| Drugs (3) | Drugs and Cosmetics rules (1) | Drugs of abuse (1) |
| drug–drug gliclazide (1) | Drug–drug interaction (1) | Dry extract cinnamon (1) |
| Drying techniques (1) | DSPC (1) | Dual Therapy (1) |
| dual-target-directed drugs (1) | Dunaliella salina (1) | Dynamic (1) |
| Dyslipidemias (1) | Dysphagia (1) | E-Cigarettes (1) |
| E-pharmacy websites (1) | e-prescribing (1) | E. coli (1) |
| E.crispa (1) | Early Childhood Caries (1) | Early-Related Complications (1) |
| Eastern province (1) | EC50 values (1) | Economic (1) |
| Economic burden (1) | Edaravone (1) | Eddy’s hot plate method. (1) |
| edema (1) | Edible flowers (1) | Editorial (24) |
| Education (2) | Educational excellence (1) | efavirenz (2) |
| Efficacy. (1) | EGCG (1) | Egfr (1) |
| egg albumin microspheres (1) | Elderly (1) | Elderly Patients (1) |
| Electrochemical (1) | electrolyte release (1) | electrolytes (1) |
| Electron beam radiation (1) | Electronic prescribing (1) | Electronic prescription (1) |
| Electroporation (1) | Elevated plus maze (1) | elevated plus maze model (1) |
| Elisa (1) | Emblica offi cinalis (1) | Emergency contraception (1) |
| Emodin (1) | Emotional (1) | Emotional domain (1) |
| Emulgel (1) | Emulsification and Solvent Evaporation (1) | emulsion solvent diffusion method (1) |
| emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) | Endocrine disruptor (1) |
| Endophytes (1) | Endothelial cells (1) | endothelial Nitric Oxide Synthase (1) |
| Endothelial progenitor cells (1) | Endothelium (1) | Endothelium. (1) |
| Enicostemma littorale (1) | Entire plant (1) | Entrapment afficiency (1) |
| entrapment efficiency (2) | Envenoming (1) | Environmental domain (1) |
| Environmental Factors (1) | Enzymatic hydrolysis (1) | Enzyme kinetics (1) |
| eosinophil (1) | Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) |
| Epigenetics (1) | epilepsy (5) | Epithelial ovarian cancer (1) |
| EQ5D (1) | erbal drugs (1) | erice declaration (1) |
| Erythema (1) | Erythrina indica (1) | Erythrina variegata (1) |
| Erythrocyte sedimentation rate (1) | Erythroderma (1) | erythropoietin (2) |
| Escherichia coli (1) | Escitalopram oxalate (1) | esomeprazole (1) |
| Essential drugs (1) | Essential hypertension (2) | Essential medicine (1) |
| essential medicines (1) | essential oil (5) | essential oil composition (1) |
| Essential principles (1) | Esthetics Dental (1) | Estimated Glomerular Filtration Rate (1) |
| Estrogen receptor alpha (1) | Ethanol (1) | Ethanol extract (1) |
| ethanolic extracts (1) | Ethiopia (2) | ethnicity (2) |
| Ethnomedicine (1) | Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) |
| Ethyl acetate (1) | Ethyl acetate fraction (1) | ethyl cellulose (2) |
| ethylcellulose (3) | ethylene glycol (2) | Eucalyptus (1) |
| Eucalyptus hybrid (1) | Eucalyptus oil (2) | eudragit (1) |
| Eudragit RL 100 (1) | eudragit S100 (2) | Eudragit-L100 (1) |
| Eudragit® S100 (1) | Eugenol (1) | Euphorbia hirta leaves (1) |
| Eurycoma Longifolia Jack (1) | Evaluation (1) | Ex vivo tissue entrapment (1) |
| ex-vivo performance (1) | Ex-vivo permeation (1) | Ex-vivo study (1) |
| Exacerbation (1) | Excision wound model (1) | Expectoration (1) |
| experiences (1) | Experiential learning (1) | Experimental ischemic stroke (1) |
| experimental study (1) | Expired medicines (1) | Expiry drugs (1) |
| Exports (1) | Expression profile (1) | Extract (1) |
| Extrapyramidal side-effects (1) | extrinsic stains (1) | extrusion (1) |
| Eye lens (1) | Ezetimibe (2) | Fabaceae (2) |
| Facial Pain (1) | Factor analysis (1) | factorial design (5) |
| Factors (1) | Factors associated with medication non-adherence (1) | Falcipain-2 (1) |
| Family Planning Services (1) | Family satisfaction (1) | family therapy (1) |
| famotidine (2) | fast disintegrating tablet (1) | Fast Disintegrating Tablets. (1) |
| Fast dissolving film (1) | Fast dissolving films (1) | Fast dissolving tablets (1) |
| Fasting serum insulin level (1) | Fat (1) | Fatty acid profile (1) |
| FC reagent (1) | FDA AERS Database (1) | FDA Approval (1) |
| Fenugreek (1) | Ferric reducing antioxidant power assay (1) | Ferritin (1) |
| Ferrous sulfate (1) | Fialuridine', (1) | Ficus bengalensis (1) |
| Ficus bengalensis (Moraceae) (1) | Ficus racemosa (1) | film (1) |
| film hydration (1) | First permanent molars (1) | Fixed drug eruption (1) |
| Flavonoid (3) | Flavonoid Compounds (1) | Flavonoid fraction (1) |
| flavonoids (3) | Flavoxate HCl (1) | FlK-1 (1) |
| Floating beads (1) | floating controlled drug-delivery system (1) | Floating drug delivery system (1) |
| floating lag time (1) | Floating tablets (1) | Floriculture (1) |
| fluoroquinoes (1) | Fluoxetine (1) | Flupritine maleate (1) |
| flurbiprofen (1) | Flux (1) | FMCG (1) |
| folkloric use (1) | Food drug and cosmetic act (1) | Forced degradation (3) |
| Forced degradation studies (1) | forced swim test (1) | Formulary (1) |
| Formulary. (1) | Formulation (4) | Formulation and development (1) |
| Fourier transform infra red spectroscopic (1) | FPG (1) | FPGEE (1) |
| Fraction (1) | Franz Diffusion Cell (3) | free radical scavenger (1) |
| Free radicals. (1) | Freeze-drying (1) | Freund’s complete adjuvant (1) |
| Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) | Frusemide-induced complications (1) |
| FTIR (4) | Fumes (1) | furosemide (1) |
| G6PD deficiency (1) | Galacto-Oligosaccharide (GOS) (1) | Galic Acid (1) |
| gallic acid (3) | Gamma irradiation (1) | Gangrenous (1) |
| Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) |
| Garcinia imberti (1) | Garcinia imberti bourd (1) | Garcinia indica (1) |
| Garcinia latissima (1) | gaseous contact (1) | gastric treatment (1) |
| Gastric ulcer (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
| gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
| GC-MS (1) | GC-MS analysis (2) | GC-MS. (1) |
| GDP (1) | Gelatin (1) | Gelling Capacity. (1) |
| Gels (1) | Gemcitabine HCl (GCH) (1) | gemfibrozil (1) |
| Gender (1) | Gender and HIV. (1) | Gene expression (1) |
| Gene expressions (1) | Gene modification (1) | Gene silencing (1) |
| General medicine (1) | Generic (2) | generic drugs (2) |
| Generic medicines (2) | Generic name. (1) | Generic substitution (1) |
| Generics (1) | Genetic polymorphisms (1) | genetic Signature (1) |
| Genotoxin (1) | Genotype frequency (1) | Gentamicin (4) |
| gentamicin sulfate (2) | Geriatrics (3) | GFAP (1) |
| Gibb’s reagent (1) | Gina criteria (1) | Ginger (1) |
| Gingival hyperplasia (1) | Gingival hypertrophy (1) | gingival pocket (1) |
| Gingival recession (1) | Gingival thickness (1) | Gladiolus segetum (1) |
| glibenclamide (4) | gliclazide (2) | Glimepiride (2) |
| glimepride (1) | Glipizide (3) | glitazars (1) |
| Global education (1) | Global publications (1) | Glomerulonephritis (1) |
| Glucagon (1) | Glucocorticoids (1) | Glucose (1) |
| glucose tolerance test (1) | glutathione (1) | Glycemic Control (1) |
| Glycerin (1) | Glycerine (1) | Glycine max (1) |
| Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) |
| Goal orientation (1) | Goldenhar syndrome (1) | good manufacturing practices (1) |
| Gotu kola leaves extract (1) | GPx (1) | Graft Rejection (1) |
| Graft Survival (1) | Grafting (1) | Gram negative (1) |
| Gram positive (1) | Grape seed extract (1) | Grape seed oil (1) |
| Grapes seed extract (1) | Gravimetry (1) | Grazing angle X-ray diffraction (1) |
| Green tea (1) | Green Tea Leaves Extract (2) | Griseofulvin (1) |
| GSH (2) | guanyl cyclase stimulator (1) | Guest Editorial (1) |
| Guidelines (1) | Gulf cooperation council (1) | Gum and fat fractions (1) |
| Gum arab (1) | Gymnema Sylvestre (2) | GYTS (1) |
| H+ (1) | H-460 (1) | H2 Receptor Antagonist (1) |
| H2O2 (1) | HAART (1) | Haematological (1) |
| Haemoglobin (1) | Haemolysis (1) | Haemolytic ratio. (1) |
| Hair dye. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
| Hajj (1) | haloperidol (1) | Hand and Foot Syndrome (1) |
| hardness (1) | Haritaki (1) | harmacotherapy-based problems (1) |
| Harmonization (2) | Hazardous drugs (1) | HbA1C (2) |
| HBV (1) | HCT: Hydrocholrothiazide. (1) | HDAC4 (1) |
| HDAC7 (1) | head twitch (1) | Health benefits (1) |
| Health Care Costs (1) | Health care profession (1) | health care professionals (1) |
| health care students (1) | Health care. (1) | Health Expenditures (1) |
| Health Hazard (1) | Health informatics (1) | Health Information Technology (1) |
| Health problems (1) | Health Professionals (1) | Health related quality of life (1) |
| Health Services Accessibility (1) | Healthcare (4) | healthcare communication (1) |
| Healthcare Delivery (1) | healthcare expenditure (1) | Healthcare Professionals (1) |
| healthcare providers (1) | Healthy volunteers (1) | heart failure (2) |
| Heat-shock (1) | Hematological parameters (1) | hematological toxicity (1) |
| Hematology (2) | Hematoma (1) | Hematopoietic progenitors (1) |
| Hemodialysis (2) | Hemoglobin (1) | Heparin (1) |
| hepatic impairment (1) | Hepatitis (1) | Hepatitis B (1) |
| Hepatitis B virus core protein (1) | Hepatocellular (1) | Hepatocurative (1) |
| hepatoprotective (2) | hepatoprotective activity (3) | Hepatotoxicity (1) |
| HER1 (1) | HER2 (1) | HER3 (1) |
| HER4 (1) | Herbal active ingredients (1) | Herbal drugs (1) |
| Herbal medications (1) | Herbal medicine (2) | herbal medicines (1) |
| Herbal therapy (1) | Herbaldb (1) | HET-CAM (1) |
| Heterocyclic compound (1) | Heterotopic Pregnancy (1) | Hex (1) |
| Hexane (1) | Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) |
| High fat diet (2) | High Fat Diet Model (1) | High impact resin (1) |
| high performance liquid chromatography (1) | high performance thin layer chromatography (1) | High-density lipoprotein cholesterol (1) |
| High-fat diet (1) | high-performance liquid chromatography (2) | High-throughput screening (1) |
| Higher education (1) | highly active antiretroviral therapy (1) | Highly Cited Papers (1) |
| Himatanthus drasticus (1) | Hip Arthroplasty (1) | Hirsutism (2) |
| Histocompatibility. (1) | Histological studies. (1) | Histopathological studies (1) |
| Histopathology (2) | HIV (1) | HIV associated dementia. (1) |
| HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) |
| HL-60 and K-562 (1) | HLA (1) | HMG-CoA Reductase (1) |
| homology modeling (1) | Honey (1) | Honeycomb (1) |
| Hordeum vulgare (1) | Hordeum vulgare hull (1) | Horticulture (1) |
| Hospital pharmacy (2) | hospitalized children (1) | hospitalized patients (1) |
| Hospitals (1) | host (1) | Host-guest interactions (1) |
| hot plate (1) | HP-ß Cyclodextrin complexes (1) | HPLC (8) |
| HPLC (High Performance Liquid Chromatography) Ornidazole (1) | HPLC method validation (1) | HPLC. (1) |
| HPMC (1) | HPMC capsules (1) | HPMC K100M (2) |
| HPMC K4M (1) | HPTLC (7) | HQLQ (1) |
| HRQoL (3) | HSV-1 (1) | Human breast cancer cells (1) |
| Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) |
| Human Papillomavirus (1) | Human plasma (2) | human plasma level (1) |
| Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) | Hydnocarpus Pentandra (1) |
| Hydralazine hydrochloride (1) | Hydroalcoholic (1) | hydrochlorothiazide (1) |
| Hydrochlorthiazide (1) | hydrogel (2) | Hydrogels (1) |
| hydrogen sulfide (1) | hydrogenated castor oil (1) | Hydrophilic drugs (1) |
| Hydrophillic sealants (1) | Hydrophobic sealants (1) | Hydrotrophy (1) |
| hydroxy propyl methyl cellulose (1) | Hydroxyl radical (1) | hydroxypropyl cellulose (1) |
| hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (1) | Hydroxypropyl methylcellulose E15 (1) |
| Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
| Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
| Hyperglycemia (1) | Hyperglycemic (3) | Hyperglycemic mice (1) |
| Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
| Hypersensitivity (1) | hypertension (6) | Hypertension( HTN) (1) |
| Hypertensive’s (1) | Hyperthyroidism (1) | hypertriglyceridemia (2) |
| Hypertrophy (1) | Hyperzincuria (1) | Hyphenated system (1) |
| hypoglycemic (1) | Hypoglycemic activity (1) | hypolipidemic (1) |
| Hypothyroidism (1) | Hypozincaemia (1) | IBD (1) |
| IBD - Inflammatory Bowel Disease (1) | IC50 (2) | ICH (2) |
| ICH guidelines (2) | ICP22 (US1) gene (1) | IL-17 (1) |
| IL-6 (2) | IL-MAE (2) | Illiterate (1) |
| Iloperidone (1) | image analysis (1) | imidazole (1) |
| Immune response (1) | Immune suppression (1) | immunocytochemistry (1) |
| Immunoinformatics (1) | Immunological response (1) | Immunomodulatory (1) |
| Immunomodulatory effect (1) | Impacted (1) | Improving (1) |
| Impurity (1) | In silico (2) | in situ gelation (1) |
| in vitro (4) | In vitro kinetics (1) | In vitro penetration lotion (1) |
| In vitro penetration test (1) | In vitro Penetration Test. (1) | In vitro release (1) |
| In vitro–In vivo (1) | in vivo (1) | In vivo kinetics (1) |
| In-patien (1) | in-vitro dissolution study (1) | In-vitro skin permeation (1) |
| Inclusion complex (1) | inclusion complexes (2) | indexed cost (1) |
| India (8) | India. (1) | Indian context (1) |
| Indian Traditional medicine (1) | Indion 234 (2) | Indion resin (1) |
| indomethacin (2) | Indonesia (2) | Indonesian Herbal Database. (1) |
| Indonesian National Health Insurance (1) | Industry (2) | Inequality (1) |
| infarct size (1) | Infection prevention (1) | infective endocarditis (1) |
| infertility (1) | Infit and outfit indices (1) | inflammation (3) |
| inflammatory bowel disease (2) | Information need (1) | Information system (1) |
| Information Technology Officers (1) | Information tool (1) | Inhibitor MDM2 (1) |
| Inhibitory activity (1) | innovation ecosystems (1) | inorganic salts. (1) |
| INR (1) | inß ammation (2) | inß ammatory bowel diseases (1) |
| Insilico anticancer screening (1) | insulin (5) | Insulin receptor (1) |
| Insulin regimen (1) | insulin resistance (1) | Insulin resistance. (1) |
| insulin use in primary care (1) | Insulinophobia (1) | Integrase inhibitor (1) |
| Integrated Courses (1) | integrated economic analysis (1) | Intellectual Property l (1) |
| Intellectual property rights (1) | intelligent tutoring (1) | Intensive care unit (1) |
| Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) | interaction (2) |
| interferon (1) | interleukins (1) | International Collaboration (1) |
| International HIV dementia scale (IHDS) (1) | international organization (1) | international organizations (1) |
| international trade (1) | Internet (1) | Internet pharmacy (1) |
| interpretation (1) | Interventional tool (1) | Interventions (1) |
| Intervertebral disc C4/5 and C5/6 (1) | Intracanal medicament (1) | intraocular presuure (1) |
| Intrauterine Pregnancy (1) | Intravenous (1) | inventory index (1) |
| inventory management (3) | investigators (1) | Invited Article (2) |
| ion pair complex (1) | Ionic gelation (1) | Ionic liquid (3) |
| Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) | ionotropic gelation (1) |
| iontophoresis (2) | Ipsilateral symptoms (1) | Iraq (1) |
| Iridoid glycoside (1) | iron chelation therapy (1) | Irrational (1) |
| Irrigation (1) | Irvingia gabonensis (1) | isatin (3) |
| ischemia (1) | ischemia-reperfusion injury (1) | Ischemic (1) |
| ischemic heart disease (1) | ISO (1) | isoniazid (2) |
| isonicotinohydrazide (1) | Isoprinosine (1) | Isopropyl myristate (1) |
| isoproterenol (1) | isoxazoline (1) | itopride HCl (1) |
| JNC 8 Guidelines. (1) | Journal (1) | Jurkat (1) |
| K+-ATPase β subunit (1) | K+ATP channel (1) | K-CAPS (1) |
| K562 (1) | Kaffir lime (1) | Kajjali (1) |
| Kalanchoe Pinnata (1) | KAP (2) | KAP study (1) |
| Kappa Concordant value (1) | Kappa. (1) | Karachi (2) |
| Kathakakhadiradi kashyam (1) | Kati chakrasana (1) | Kernel powder (1) |
| Ketamine (1) | Ketoprofen (1) | Ketorolac (1) |
| Ketorolac salt (1) | Key words: 5-FU (1) | Key words: Esomeprazole (1) |
| kidney (2) | Kidney Transplantation (1) | kinetic drug release (1) |
| Kinetic Modelling (1) | KMnO4 (1) | kneading method (1) |
| kneading technique (1) | knowledge (12) | Knowledge; North India (1) |
| Kumar’s score (1) | L-arginine (1) | L-Thyroxine (1) |
| L. acidophilus (1) | labeling (1) | Laboratory findings. (1) |
| Lactobacilli (2) | Lactobacillus (1) | Lag period (1) |
| Lagenaria siceraria (1) | Lantana camara (1) | Lantana montevidensis (1) |
| Larvacidal (1) | Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) |
| LC-MS (1) | LC-MS/MS (1) | LC/MS/MS (1) |
| LC50 (1) | LCMS/MS (1) | LC–MS/MS (1) |
| LDL-C (1) | Leaf (1) | Learning process (1) |
| leaves (4) | Leftover medicines, (1) | Leg Length (1) |
| Leptin (1) | Letter to Editor (4) | Letter to the Editor (3) |
| Letters to the Editor (6) | Leucaena leucocephala (1) | Leucas lavandulaefolia (1) |
| Levocetirizine (1) | Lexicomp (1) | Lichen planus (1) |
| Licofelone (1) | Ligand-based drug design (1) | Lightening (1) |
| Limb Length (1) | Limbs (1) | lime fruit (1) |
| Linezolid (1) | Linoleic acid (1) | lipid matrix (1) |
| lipid metabolism (2) | lipid microspheres (1) | Lipid nanocrystals (1) |
| Lipid peroxidation (3) | lipid peroxides (1) | lipid profile (1) |
| Lipid profile membrane bound enzymes (1) | lipids (1) | lipoic acid (1) |
| liposome (1) | Lippia (1) | lithium toxicity (1) |
| Live-well™ (1) | liver function (2) | Liver necrosis (1) |
| Liver tonic (1) | Liver Transplantation (1) | Local drug delivery (1) |
| locomotor activity (1) | Low-density lipoprotein cholesterol (1) | Lozenges (1) |
| Luffa echinata (1) | Luminesce (1) | Lung (1) |
| Lung cancer (3) | Lupenoic acid (1) | Lupus (1) |
| Lycatab C (1) | Lympadenopathy (1) | lymphadenitis (1) |
| Lymphoma (1) | Lysozyme (1) | M. tuberculosis H37Rv (1) |
| Maceration (1) | Macromicroscopy study (1) | Macrophage cell line (1) |
| Mahkoside A (1) | Major Contributed Organizations (1) | Malaysia (5) |
| Malaysia. (1) | Malaysian. (1) | Male (1) |
| Malignant transformation (1) | malondialdehyde (2) | Maltodextrin (2) |
| Mammary carcinoma (1) | Mandibular hypoplasia (1) | Mangiferin (1) |
| Mangosteen Peels (1) | manidipine dihydrochloride (1) | Mannich base (1) |
| Mannich Bases (1) | Marine fungi compounds (1) | Mast cell (1) |
| Maternal Care. (1) | Mathematical modeling (1) | matrix (1) |
| Matrix Tablet (1) | matrix tablets (3) | MCF-7 (1) |
| MDA (2) | MDR-TB (2) | mean age (1) |
| Mechanism (1) | mechanisms (1) | Meclizine HCl (1) |
| Medical (1) | Medical and non-medical (1) | medical costs (1) |
| Medical device (1) | Medical device recalls (1) | medical errors (1) |
| Medical informatics (1) | Medical Inpatients (1) | Medical practitioner (1) |
| Medical Representative (1) | Medical Respresntative (1) | Medical sales representative (1) |
| Medical students (2) | medication adherence (5) | medication adherence behaviour (1) |
| medication error (2) | Medication errors (1) | Medication non-adherence (1) |
| Medication reconciliation (1) | Medication regimen complexity (1) | medication safety (1) |
| Medication taking (1) | Medication understanding (1) | medication-/drug-related problem (MRP/DRP) (1) |
| Medicinal ornamental plants (1) | Medicinal plants (4) | Medicine (2) |
| Medicine consumers (1) | Medicine disposal (1) | medicine-use practices (1) |
| Medicines storage (1) | Medicines wastage (1) | Mediterranean diet (1) |
| Melanesia (1) | Melastoma malabathricum (1) | Melinjo (2) |
| Meloxicam (1) | Memory (1) | Memory and learning. (1) |
| Men (1) | Menaquinone-4 (1) | Menstrual cycle (1) |
| Mental health (1) | Mental health services. (1) | Mentha arvensis (1) |
| mesalamine (1) | Metabolic ratio (1) | Metabolic syndrome (1) |
| Metabolism (1) | Metabolite profiling (1) | Metabomics (1) |
| metagenomic (1) | metformin (7) | metformin hydrochloride (1) |
| Methanol (1) | methanolic extract (1) | methocel (1) |
| method development (3) | Method optimization (1) | method validation (3) |
| Methotrexate (1) | methyl orange (1) | methyl-b cyclodextrin (1) |
| metoprolol tartarate (1) | MetS (1) | Mevalonate (1) |
| Micro emulsion (2) | Micro particles. (1) | Micro-emulsion (1) |
| microbial contamination (1) | Microbiological (1) | Microbroth dilution (1) |
| Microcapsules (1) | microcrystalline cellulose (5) | microdilution (1) |
| Microdosing (1) | Microencapsules (1) | microneedles (1) |
| Micronucleus assay (1) | microparticles (1) | microsphere (1) |
| Microsphere Phytosome (1) | microspheres (6) | microtriches (1) |
| Microwave assisted extraction (1) | Microwave-Assisted Extraction (2) | miglitol (1) |
| Migraine (2) | migraine management, (1) | Mild neurocognitive disorder (1) |
| Milk (1) | Milnacipran (1) | Mimosa pudica (1) |
| Mineral trioxide aggregate (1) | minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) |
| mismatches (1) | mitochondria (1) | Mix mode (1) |
| MLR (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) | Modafinil (1) |
| Modeling (1) | modern medicine (1) | modified melt dispersion technique (1) |
| Modified Starches (1) | MODY (1) | Mol inspiration (1) |
| Molecular characterization (1) | Molecular docking (10) | molecular docking and anti cancer activity. (1) |
| Molecular Docking. (1) | Molecular Dynamic (1) | Molecular dynamics (3) |
| Molecular Dynamics Simulations (1) | Molecular Imprinted Polymer (1) | Molecular mimicry (1) |
| Momordica charantia (1) | Momordicin II Natural Products (1) | monoamine oxidase B (1) |
| Monocots (1) | Monophyletic (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | moraceae (1) |
| Morbidity (1) | Morin and validation (1) | Moringa oleifera (2) |
| Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) | Morocco (1) |
| Mortality (3) | Morus alba (2) | Mosquito repellent (1) |
| Mouth Dissolving Tablets (1) | mouth-dissolving film, (1) | MPO activity (1) |
| MPTP (1) | MTT Assay (2) | MTT method (1) |
| MUC2 (1) | MUC6 (1) | Mucoadhesive (1) |
| Mucoadhesive agent (1) | mucoadhesive formulation (1) | Mucoadhesive Oral In situ gel (1) |
| mucoadhesives (1) | mucodhesive (1) | Mulberry (1) |
| multi granules (1) | Multi Organ Failure (1) | multidrug resistant pathogens (1) |
| Multikinase Inhibitor (1) | multiparticulates (1) | multiparticulates dosage form (1) |
| Multiple myeloma (1) | multiple regression (1) | multiple regression analysis (1) |
| Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) | Mycobacterium tuberculosis. (1) |
| Mycophenolate mofetil (1) | Mycophenolic acid (1) | Myeloperoxidase (1) |
| myocardial infarction (1) | Myomectomy. (1) | Myrica esculenta (1) |
| Myristicin (1) | Myrobalan (1) | N-aminoimidazoles (1) |
| N-napthyl ethylene diamine dihydrochloride (1) | Na+/K+-Atpase (1) | NABP (1) |
| NACO. (1) | Nadi shuddhi pranayama (1) | Naftopidil (1) |
| Naltrexone (1) | nano size (1) | Nanoemulsion (1) |
| Nanoformulation (2) | nanoformulations (1) | Nanonization. (1) |
| Nanopacticle (1) | Nanoparticle (1) | Nanoparticles (10) |
| Nanosuspension (1) | Nanosuspension tablets (1) | Nanosuspensions (1) |
| Naphthoquinone derivative (1) | NAPLEX (1) | naproxen (1) |
| Naranjo (1) | Naranjo algorithm (2) | Naranjo algorithm. (1) |
| Naranjo’s ADR probability scale (1) | Narikel Lavan (1) | Narrow therapeutic index drugs (1) |
| Nasal gel (1) | Nateglinide (1) | National Fomulary (1) |
| National Formulary (2) | National Health and Morbidity Surveys (1) | National Public Health Programs (1) |
| Natural (1) | natural compounds (3) | Natural deep eutectic solvent (1) |
| Natural Polymers (1) | natural products (3) | NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) |
| Nebivolol (2) | nebivolol hydrochloride (1) | Necrosis. (1) |
| need assessment (1) | Nephroprotective (3) | Nephrotic syndrome (1) |
| Nephrotoxicity (1) | Nerium indicum (1) | neuropathy (1) |
| Neurosurgical (1) | neutropenia (1) | nevirapine (1) |
| new molecule (1) | Newborns (1) | Nicorandil (1) |
| Nicotine (1) | Nicotine dependence (1) | Nifedipine. (1) |
| Nigeria. (1) | nigrostriatal pathway (1) | Nil (11) |
| Nill (19) | Nimesulide (1) | niosome (1) |
| Niosomes (1) | Nitric acid (1) | Nitric oxide (3) |
| Nitrogen starvation (1) | NK cell (1) | NMDA (1) |
| NMDA receptors (1) | Noccik Kudinir (1) | Nodular skin lesions (1) |
| Non-linear (1) | non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) |
| Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) | nonamers. (1) |
| noncommunicable disease (1) | noncompliance (1) | Nonionic surfactants (1) |
| Nonomuraea longicatena (1) | nootropic (1) | Norfloxacin (1) |
| Normoglycemic rats (1) | northeast India (1) | Nose to brain delivery (1) |
| Nosocomial infections (1) | Nothopanax scutellarium (1) | NSAIDs (1) |
| Nuclear medicine (1) | nuclear pharmacy (1) | Nucleo CMP (1) |
| Nude mice (1) | Nutmeg oil (1) | Nutraceuticals (1) |
| Nutrient starvation (1) | Nutrition (1) | Nystagmus Phenytoin toxicity (1) |
| O-Phenylene diamine (1) | Obesity (4) | Occupational health (1) |
| Ocimum gratissimum (1) | Off-label (1) | offending drugs (1) |
| OHI (1) | Okra Mucilage (1) | Olmesartan (1) |
| olmesartan medoxomil (1) | Omega-6 fatty acid (1) | Omeprazole. (1) |
| Omics (1) | Oncology. (1) | Oncopharmacists (1) |
| ondansetron (3) | ondansetron hydrochloride (1) | Online health screening (1) |
| Online pharmacies (1) | OPD – Outpatient Department. (1) | open field (1) |
| Ophthalmic (1) | ophthalmic delivery (1) | ophthalmic inserts (1) |
| Opinion (1) | Opportunities (1) | Opportunity (1) |
| Optimal stress (1) | optimization (8) | Oral bacteria (1) |
| Oral cancer (2) | Oral disease (1) | Oral diseases (1) |
| oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
| Oral hypoglycemic drugs (1) | oral insulin (1) | Oral manifestations (1) |
| Oral Medicine (1) | Oral Probiotics (1) | Oral Rehabilitation (1) |
| Oral Surgery (2) | Organ Toxicities (1) | organic acids (1) |
| organogel (1) | Organophosphate (1) | Origanum vulgare (1) |
| Original Article (3) | Originator. (1) | Orlistat (2) |
| orodispersible tablet (1) | orodispersible tablets (2) | Oscillopsia (1) |
| Osmotic pump (1) | Osseointegration (1) | Osteoarthritis (1) |
| Osteoblast (3) | Osteoclast (2) | OTC switch (1) |
| Otomycosis (2) | Outcome therapy (1) | Outdoor patients (1) |
| Outpatient Pharmacy (1) | Outpatients (1) | ovalbumin (1) |
| Ovarian (1) | Ovarian Cyst (1) | Over the counter (1) |
| Over-the-counter (1) | Overweight (1) | OVX (1) |
| oxazepinone (1) | oxcarbazepine (1) | Oxidation (1) |
| oxidative damage (1) | oxidative stress (6) | Oxyresveratrol (2) |
| oxytetracycline (1) | P-dimethylaminobenzaldeyde (1) | P-drug. (1) |
| P-drugs (1) | P-glycoprotein (1) | P. dulce (Fabaceae) (1) |
| p21SNFT (1) | p53 tumor suppressor gene (1) | Package insert (1) |
| Paediatric (2) | Pain (2) | Pain scale (1) |
| Pain. (1) | Painkiller (1) | pair wise procedures (1) |
| Pakistan (2) | Pakistan. (4) | Paliperidone palmitate (1) |
| Pancreatitis. (1) | Pantoprazole (1) | papain (1) |
| Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
| paracetamol (4) | Paracetamol. (2) | Parkinson’s disease (1) |
| partial least square (1) | particle size analysis (1) | PASS (1) |
| passive avoidance learning (1) | Patch (1) | patents (3) |
| Pathological response (1) | Patient (2) | Patient adherence. (1) |
| Patient Care (1) | patient counseling (1) | Patient counseling and Patient information leaflet (1) |
| patient education (1) | Patient health questionnaire (PHQ) (1) | Patient Safety (1) |
| Patient satisfaction (1) | Patient Satisfaction Questionnaire (1) | Patient Survival (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (4) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (3) | Pediatric cancer (1) |
| Pediatric Dentistry (1) | Pediculosis (1) | Pegagan extract (1) |
| PEGylation (1) | Pemphigus vulgaris (1) | Penang (1) |
| penetration (3) | penetration enhancer (1) | penetration pressure (1) |
| penicillamine (1) | Penicillins (1) | pentylenetetrazole (1) |
| PEO (1) | Peperomia pellucida (L) Kunth (1) | Peperomia pellucida (L.) Kunth (3) |
| Peppas and Higuchi’s equations (1) | Peptic Ulcer. (1) | peptide vaccine (1) |
| Peptidoglycan (1) | percentage healing of wound area (1) | perception (7) |
| Periauricular tags. (1) | pericyclic fiber (1) | Periodontal disease (1) |
| periodontal diseases (1) | Periodontal dressing (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permanent (1) | Permeation (2) |
| Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) | Persistent ulcer (1) | Personal care products (2) |
| Persons and items reliability (1) | pH dependent approach (1) | pH independence (1) |
| pH-sensitive (1) | Phaleria marcocarpha (1) | Pharm. D. Integrated (1) |
| Pharm. D. Post Baccalaureate. (1) | pharma counseling (1) | pharmaceutical (1) |
| pharmaceutical advertisements (1) | Pharmaceutical care (2) | Pharmaceutical Care service (1) |
| pharmaceutical care. (1) | pharmaceutical formulations (1) | Pharmaceutical Industry (1) |
| Pharmaceutical Marketing (1) | Pharmaceutical Services (1) | Pharmaceutical-Care (1) |
| Pharmaceutical-industries (1) | Pharmacist (4) | Pharmacist intervention (1) |
| Pharmacist intervention. (1) | pharmacist role in public health (1) | Pharmacists (2) |
| pharmacists India (1) | Pharmacodynamic (3) | Pharmacodynamic activity (1) |
| pharmacodynamics (2) | Pharmacogenetics (1) | Pharmacogenomics (1) |
| Pharmacognostic (1) | pharmacognostic standardization (1) | pharmacognostical (1) |
| Pharmacognosy (1) | pharmacognosy study (1) | Pharmacokinetic (7) |
| Pharmacokinetic interactions. (1) | pharmacokinetics (8) | Pharmacokinetics. (2) |
| Pharmacological properties (1) | Pharmacophore (3) | Pharmacovigilance (17) |
| Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) | Pharmacovigilante’s (1) |
| Pharmacovigillance (1) | pharmacy (5) | pharmacy curriculum (2) |
| Pharmacy education (1) | Pharmacy Enforcement Division (1) | Pharmacy informatics (1) |
| Pharmacy intervention (1) | Pharmacy services (1) | Pharmacy store (1) |
| Pharmacy student (1) | Pharmacy students (1) | Phase diagrams (1) |
| Phase I studies (1) | Phase rule (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | Phenolic (1) |
| phenolic compounds (2) | Phenolic content (1) | phenolics (1) |
| phenols (1) | Phenothiazine (1) | Phenytoin (4) |
| Phenytoin cold cream (1) | Phenytoin Toxicity (1) | Pheritima posthuma (1) |
| Phleboliths (1) | Phoenix dactylifera (1) | Phosphorylase kinase (1) |
| Photoprotection. (2) | Phthalates (1) | Phyllanthus emblica, (1) |
| Phylogenetic tree (1) | Phylogeny (1) | Physical activity (1) |
| Physical fitness (1) | Physical stability (1) | Physichochemical Characterization (1) |
| Physicians (4) | Physicochemical (1) | physicochemical evaluation (1) |
| physicochemical properties (1) | physiochemical descriptor (1) | Physiological role (1) |
| Phytochemical (2) | phytochemical prospection (1) | Phytochemical screening (1) |
| Phytochemicals (1) | Phytopharmaceutical drug (1) | Phytosome (1) |
| picrotoxin (1) | pictograms (1) | Pilgrims (1) |
| PIM (1) | Pinus merkusii (1) | pioglitazone (1) |
| piperazine citrate (1) | Piperine (2) | Piroxicam (2) |
| Pits and Fissures (1) | Pixel intensity. (1) | Plackett-Burman (1) |
| Plackett-Burman design (1) | plant extracts (1) | plasma (3) |
| Plasma concentration (1) | plasma concentrations (1) | Plasma creatinine (1) |
| Plasma insulin (1) | Plasma urea (1) | plasma-brain correlation (1) |
| Plasma. (1) | Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) |
| Platelet aggregation. (1) | Platelet rich fibrin membrane. (1) | Pleiotropic effects (1) |
| PLGA (1) | PLS (1) | PLSR (1) |
| Pluronic F 127 (1) | PM6 (1) | PM7 (1) |
| Pneumonia (2) | Point-measure correlation coefficients (1) | Poison (2) |
| Poisoning pattern (1) | Polarography (1) | Poloxamer 188 (1) |
| Poloxamer 407 (2) | Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) |
| Poly herbal (1) | poly(ε-caprolactone) (1) | Poly-herbal (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymeric nanoparticles (2) | Polymorphism (1) |
| polypharmacy (7) | polypharmacy in diabetes mellitus. (1) | polyphenols (1) |
| Polysaccharide (1) | polyvinyl alcohol (2) | polyvinyl pyrrolidone (1) |
| Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) | Pomalidomide (1) |
| PON1 mRNA (1) | porosity (1) | Port-A Catheter. (1) |
| Portfolio (1) | Positive and Negative stressors (1) | Positive coping strategies. (1) |
| Posology (1) | Possible mechanisms (1) | Post-antibiotic era (1) |
| Posterior reversible encephalopathy syndrome (1) | Potassium (1) | Potassium Channel (1) |
| Potassium chloride (1) | Potassium Nitrate (1) | Potential Drug-Drug Interaction (1) |
| Powder (1) | PPAR agonists (1) | PPARγ agonists. (1) |
| PPBG (1) | pPharmacokinetics (1) | PPP model (1) |
| practice (3) | practices (1) | pravastatin (1) |
| Pre ADMET (1) | pre prandial (1) | Pre University students (1) |
| Pre-authorization (1) | Prebiotic (2) | Precipitation (1) |
| precise (1) | Precision (1) | Predictors (1) |
| Pregabalin (1) | Pregnancy (3) | preliminary screening (1) |
| Premna esculenta (1) | prescriber (1) | Prescribing (1) |
| Prescribing errors (1) | Prescribing pattern. (1) | Prescription (3) |
| Prescription audit (1) | Prescription error. (1) | prescription monitoring (1) |
| prescription only medicines (1) | Prescription pattern (2) | Prescription refill (1) |
| Prescription review (1) | pressure dependent approach (1) | Prevalence (4) |
| Prevention. (1) | Price variation (1) | Primary health care (2) |
| Primary Health Care. (1) | Principal component analysis (1) | principal component regression (1) |
| Pristane (1) | Private Medical College (1) | PRO (1) |
| Probable (1) | Probiotic (1) | Probiotics (1) |
| Problem-based learning (1) | process capability (1) | Process parameters. (1) |
| Products with Antimicrobial Action. (1) | progesterone (1) | Proniosomal gel (1) |
| propolis (3) | Proportional reporting ratio (1) | propranol hydrochloride (1) |
| Propranolol hydrochloride (1) | Prospection (1) | Prospective Study (2) |
| prostaglandins (1) | Prosthesis Coloring (1) | Proteasome activity (1) |
| protein proÞ le (1) | proteolytic enzymes (1) | Proton adduct (1) |
| Proton Pump Inhibitor (2) | Proton-pump Inhibitors (1) | Protransfersome (1) |
| Prteomics (1) | Pseudo ternary phase diagrams (1) | Pseudomonas aeruginosa (1) |
| Psidium Guajava (1) | Psychological mindedness (1) | Psychomotor (1) |
| Psychosis (2) | Psychotropic drugs (1) | Psychotropics (1) |
| Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) | Public behavior (1) |
| Public health hospital (1) | Public hospital (2) | Public Service (1) |
| Publication (1) | Publications (2) | Pulmonary Fibrosis (1) |
| pulmonary hypertension (1) | Pulmonary resection (1) | Pulmonary toxicity (1) |
| Pulse wave velocity (1) | Punica granatum (1) | pyrazine (1) |
| pyrazoline (1) | pyrazolines (1) | Pyrimidine (1) |
| Q1F (1) | QOL (1) | QSAR (3) |
| qualitative (1) | Qualitative analysis (1) | qualitative study (1) |
| Quality (1) | quality assurance (1) | Quality Control (1) |
| Quality Indicators (1) | quality of internet information (1) | quality of life (7) |
| quantitative structure-activity relationship (1) | Quercetin (2) | Questionnaire (1) |
| quinazolin-4(3H)one (1) | quinazolinone (1) | Quinazolinone. (1) |
| quinoline derivatives (1) | R2 values (1) | Rabbit plasma (1) |
| Rabbits. (1) | radical scavenger (1) | radicals (1) |
| Radiculopathy (1) | Radiology Unit (1) | radiopharmaceuticals (1) |
| radiopharmacy (1) | Radioprotective (1) | Raillietina echinobothrida (1) |
| raloxifene hydrochloride (1) | Raltegravir potassium (1) | Raman spectroscopy (2) |
| ramipril (2) | ranitidine (1) | Ranitidine hydrochloride (2) |
| Ranitidine’. (1) | ranolazine (1) | Ransmission electron microscopy (1) |
| Rapid disintegration (1) | Rasagiline mesylate (1) | Rat (1) |
| ratio test procedures (1) | Rational pharmacotherapy. (1) | Rational prescribing (1) |
| Rational use of Medication (1) | Rational use of medicine (1) | rational use of medicines (1) |
| rats (1) | Rattus novergicus (1) | Re-emerging viral infections (1) |
| re-precipitation (1) | recognized standards (1) | recovery studies (1) |
| Red ginger (1) | Reduction (1) | Reflective pedagogy paradigm (1) |
| reforms (1) | Regeneration (1) | Regression analysis (2) |
| Regressions statistics (1) | Regulation (1) | Regulations (1) |
| regulatory (2) | Regulatory affairs (1) | regulatory system (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| Repurposing (1) | research (1) | Research Skills. (1) |
| reserpine (1) | Resident doctors (1) | Resistance (4) |
| Resistant starch (1) | Resource poor setting (1) | Respiratory tract (1) |
| Response Surface Methodology (2) | Response surface methodology. (1) | Response to antiretroviral therapy (1) |
| Resveratrol (2) | retail pharmacy (1) | Retention. (1) |
| Retinopathy (1) | retrospective cohort (1) | Retrospective study (2) |
| reversed-phase chromatography (1) | Rhabdomyolysis (1) | Rhaphidophora pinnata (1) |
| rhizomes (1) | Riboflavin (1) | Rice Bran Oil (1) |
| Rifampicin (1) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
| Riociguat (1) | Risk factor. (1) | Risk factors (4) |
| Risk Factors. (1) | Risk rating (1) | Rituximab (1) |
| rivastigmine (1) | RNA interference (1) | RNAi (1) |
| RNAi technology (1) | RNTCP (2) | Rodenticides (1) |
| root (1) | Root canal infection (1) | Roots extract (2) |
| Ropinirole (1) | rosuvastatin (2) | rosuvastatin calcium (1) |
| Royal Malaysian Custom Officer (1) | RP-HPLC (8) | RP-HPLC method (1) |
| RP-TLC/Densitometry (1) | RP-UFLC method (1) | RT-qPCR (1) |
| Rubus fraxinifolius (1) | Rubus rosifolius (1) | rupatadine (1) |
| rutin (1) | ß avonoids (2) | S. mutans (1) |
| S.salivarius (1) | S.sanguis (1) | Saccharin (1) |
| Safe handling guidelines (1) | Safety (1) | Safoof razyanaj (1) |
| Safoof-e- Binai (1) | Sage (1) | Saponin (2) |
| saponins (1) | Sappan wood (1) | Saraschandra (1) |
| Satisfaction (1) | Saudi Arabia (3) | Saudi National Pharmacovigilance Centre (Saudi NPC) (1) |
| Saussurea (1) | Saussurea lappa (1) | scanning electron microscopy (3) |
| Schizophrenia (1) | Scientific Advertisements (1) | Scientometrics (4) |
| sclerotherapy (1) | Scores. (1) | Se- DeM ODT Expert system (1) |
| Second-line agents (1) | Secondary Level (2) | Sedation (1) |
| Sedation in pediatric patients (1) | Sedation scale (1) | seizure outcome (1) |
| Seizures (1) | Selected area electron diffraction (1) | Self efficacy. (1) |
| Self medication (1) | self-emulsifying drug delivery system (1) | Self-Harm (1) |
| self-medication (6) | self-nanoemulsification (1) | Selfmedication (1) |
| Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
| sensory cortical activity. (1) | separation (1) | sepbox (1) |
| Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
| Serum (1) | Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) |
| Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) | Serum Vitamin D (1) |
| Serum. (1) | sesame oil (1) | severe febrile neutropenia (1) |
| Severe Neck Pain (1) | Severe sepsis (1) | Severity (2) |
| Sexual dysfunction in diabetes (1) | SF-36 (1) | Shodhana (1) |
| Short Communication (3) | short-term memory (1) | Sida rhomboidea.Roxb (1) |
| Side effect (1) | signal detection (1) | Signal detection. (1) |
| Signs and Symtoms (2) | Silver nanoparticles (1) | silymarin (1) |
| Similarity factor (1) | similarity factor (f2) (2) | simplex lattice (1) |
| Simplex Lattice Design (2) | simultaneous determination (2) | simultaneous extraction (1) |
| simvastatin (1) | simvastatin. (1) | Single nucleotide polymorphism (1) |
| sintering (1) | siRNA (1) | siRNA. (2) |
| SIRT1 (1) | Sirtuin (1) | six sigma (1) |
| SJS (1) | Skin drug test (1) | Skin whitening (1) |
| SLAM markers (1) | SLS (1) | Smix. (1) |
| Smoking (1) | smoking cessation. (1) | Smoking. (1) |
| smooth muscle cells (1) | Snake bite (1) | SNEDDS (2) |
| Snyder Test (1) | sobatum (1) | Social Media (1) |
| Social sexual. (1) | Sociodemographic factors (1) | Socioeconomic status (1) |
| SOD (1) | Sodium (1) | sodium alginate (1) |
| sodium alginate. (2) | sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) |
| Sodium starch glycolate (SSG) (1) | Sodium Valproate (1) | Sofosbuvir (1) |
| Solanum nigrum (1) | Solanum trilobatum (1) | Solanum viarum (1) |
| Solanum xanthocarpum, (1) | Solasodine (1) | solid dispersion (5) |
| solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) | Solid Phase Extraction (1) |
| solubility (6) | Solubility enhancement (1) | Solubility. (1) |
| solvent casting (1) | solvent evaporation (3) | Solvent evaporation. (1) |
| sonication time (1) | sonophoresis (1) | Sorafenib (1) |
| Spacedrepetition. (1) | spasmolytic (1) | speciÞ city (1) |
| Spectrometric (1) | spectrophotometry (2) | sperm count (2) |
| SPF (1) | Spiro compounds (1) | Spleen colony assay (1) |
| Sponge implantation (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| SPSS 20. (1) | ST segment elevation (1) | stability (1) |
| stability indicating (1) | stability indicating and validation. (1) | Stability indicating assay (1) |
| Stability indicating assay method (1) | stability indicating method of artemether (1) | stability indicating. (1) |
| Stability of the physical properties (1) | Stability test (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (6) |
| Standardized Zscore (1) | Staphylococcus aureus (1) | Staphylococcus sciuri (1) |
| Starlac (1) | Statin pathway (1) | Statins. (1) |
| Statistical Modeling (1) | Statistical optimization (1) | Stelechocarpus burahol (1) |
| Stem bark extract (1) | Stephania hernandifolia (1) | Stereospermum suaveolens (1) |
| Stereospermum tetragonum (2) | Sterilization Procedures (1) | Steroidal alkaloid (1) |
| Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) | Stilbene (1) |
| Stimulantia (1) | Stimuli (1) | Stomatitis under prosthesis (1) |
| Strabismus surgery (1) | Streptococci (1) | Streptococcus mutans (2) |
| Streptokinase (1) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) |
| Streptozotocin. (1) | stress (3) | Stress degradation (1) |
| stress studies (2) | stroke and cardiac pacemaker. (1) | Stroke prevention (1) |
| structural descriptor (1) | Structured Communication. (1) | Stryphnodendron rotundifolium (1) |
| students (3) | students’ residence (1) | Sub Clinical Hypothyroidism. (1) |
| Sub-acute Inflammation (1) | Subcutaneous fat (1) | sublingual films (1) |
| substituted acetophenones (1) | sucrase (1) | Sudan (1) |
| Sulfated polysaccharides (1) | Sulfonylurea (2) | Sulfonylureas (1) |
| Sulphorhodamine-B (1) | Sun (1) | sun protection factor (2) |
| Sunlight (1) | Sunscreens. (1) | Super disintegrants (1) |
| superdisintegrants (2) | Superdisintergrants (1) | Superoxide Dismutase. (1) |
| superoxidedismutase (1) | superporous hydrogel composite (1) | Supply Chain Management (1) |
| support staff. (1) | Surface properties (1) | surfactant (1) |
| surfactants (2) | Surgical cutters (1) | surgical prophylaxis. (1) |
| Surgical treatment (1) | Surgical. (1) | Survey questionnaire (1) |
| survey. (1) | Survival rate (1) | sustained release (3) |
| sustained release pellets (1) | sustained release. (1) | Sweet orange peel extract (Citrus sinensis) (1) |
| swelling index (2) | swelling studies (1) | SWOT (1) |
| Symptoms (1) | Symptoms domain (1) | Synchronous spectrofluorimetry. (1) |
| Synergism. (1) | Synthesis (2) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) |
| Systematic review (1) | Systematic Review. (1) | Systemic steroids. (1) |
| Systems biotechnology (1) | Systolic dysfunction. (1) | T cell epitope (1) |
| T lymphocytes (1) | T regs (1) | Tab. Pardopa (1) |
| Tablet Compression (1) | Tacrolimus (1) | Tacrolimus Once Daily (1) |
| Tacrolimus Twice Daily. (1) | Tactile stimulation (1) | tail suspension test (1) |
| Tamarindus indica (1) | Tamilians (1) | Tamoxifen (1) |
| Target delivery (1) | Targeted drug delivery system (1) | taste masking (2) |
| tasteless complex (1) | taxane (1) | Taxanes (1) |
| Taxus baccata (1) | Teaching Hospital (1) | Technology (1) |
| technology-enhanced learning (1) | tegument (1) | telmisartan (1) |
| Temporomandibular Joint (1) | Temporomandibular Joint Disoders (1) | TEN (1) |
| Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) | Terminalia bellirica (1) |
| Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | Ternary phase diagram (1) | terpenoids (1) |
| Tertiary Care (1) | Tertiary care hospital (2) | testicular damage (1) |
| testosterone (3) | Tetrapreniltoluquinone (1) | thalassemia major (1) |
| therapeutic angiogenesis (1) | therapeutic dose (1) | therapeutic drug monitoring (2) |
| therapeutic effectiveness (1) | Thermoreversible gel (1) | Third Molar (1) |
| Thixogel (1) | Thoracomioplasty (1) | THP-1 (2) |
| Three component system (1) | thrombocytopenia (1) | Thrombolysed subjects (1) |
| Thrombolytic (1) | thrombolytic enzymes (1) | Thyme oleoresin (1) |
| Thyrotoxicosis. (1) | time dependent approach (1) | Time lag (1) |
| Timed release (1) | Tissue distribution (1) | TLC (1) |
| Tobacco (2) | Tobacco smoking (1) | tolbutamide (1) |
| Tolerance (1) | Tooth brush. (1) | Toothpaste (1) |
| Toothpaste. (1) | Topical delivery. (1) | Topical. (1) |
| Total flavonoid (1) | Total flavonoid content (2) | Total phenolic (2) |
| Total phenolic content (1) | total polyphenolic content (1) | total quality management (1) |
| toxicity (5) | Toxicity. (2) | traditional medicine (2) |
| Training of Central sterile and supply department employees (1) | tramadol HCL (1) | Tramadol Hydrochloride (1) |
| Trans-cinnamic acid (1) | Trans-resveratrol (1) | Transcriptomics. (1) |
| transdermal (2) | transfer latency (1) | Transfersome (2) |
| Transfersomes. (1) | Translation (1) | Transmucosal (1) |
| Transmucosal patch (1) | Trauma induced external inflammatory root resorption (1) | Treatment adherence. (1) |
| Treatment outcomes (1) | Treatment success rate (1) | Triacylglycerol. (1) |
| Triamcinalone Acetonide (TRIA) (1) | Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) |
| Triglycerides (1) | Trigonella foenum graecum (1) | Trigonelline (1) |
| Trinidad & Tobago (1) | trinitrobenzene sulfonic acid (1) | Triphala (1) |
| triple distilled water (1) | Triterpenoid. (1) | Triterpenoids (1) |
| Triticum aestivum. (1) | Tropaeolum majus L (1) | tropicamide (1) |
| Troponin-I (1) | Trypsin (1) | TSLP (1) |
| Tuberculosis (6) | Tuberculosis/HIV (1) | Tumor response (1) |
| Turkey (1) | Turmeric (1) | Tween 80. (1) |
| Twisted (1) | Tylophora indica (1) | Tylophorinidine. (1) |
| type 2 diabetes (2) | Type 2 diabetes mellitus (1) | Type 2 diabetes mellitus. (1) |
| type 2 diabetes. (1) | UACR (1) | UCPMP Guidelines (1) |
| Ultra-Fast Liquid Chromatography (UFLCDAD) (1) | Ultrasonic assisted extraction (1) | ultrasonication-solvent evaporation technique (1) |
| Ultrasonography (1) | Unani (1) | Unani medicine (3) |
| Uncemented (1) | Underutilization of insulin. (1) | Unethical practices. (1) |
| Unique device identification (1) | Universities (1) | Unlicensed. (1) |
| Unnecessary use. (1) | Unused drugs (1) | Unused/Unwanted medicines (1) |
| UPLC/ESI-Q-TOF-MS/MS method Validation (1) | Urban area (1) | urea (2) |
| Uremic toxins (1) | Urinary Hydrogen Peroxide (1) | Urinary tract infection (UTI) (1) |
| Urine Albumin to Creatinine Ratio (1) | Urine volume (1) | urolithiasis (1) |
| Urtica dioica L (1) | Usefulness. (1) | Uterine fibroid (1) |
| Uterine fibroids (1) | Uterine Perforation. (1) | UV derivative spectrophotometry (1) |
| UV detection (2) | UV Spectrophotometric method (1) | UV spectrophotometry (2) |
| UV-spectrophotometric method (1) | UV-spectrophotometry (2) | UV-Vis spectroscopy (1) |
| Vaccine (1) | Vaccine design (1) | vada (1) |
| vaginal gel (1) | Vaginitis. (1) | Vakrasana (1) |
| validation (19) | Validation. (1) | Valium (1) |
| Valproate (1) | valsartan (1) | Vanillin (1) |
| Vanillosmopsis arborea. (1) | vascular bundle (1) | vascular permeability (2) |
| vascular progenitors (1) | VED analysis (3) | VED analysis. (2) |
| VEGFR-2 (1) | Velpatasvir (1) | Venetoclax (1) |
| Venography and Hemangioma (1) | Venous malformations (VMs) (1) | verapamil (3) |
| Verapamil HCl (1) | Viability (1) | Vincristine. (1) |
| Vinegar (1) | VIPPS (Verified Internet Pharmacy Practice Sites) (1) | Virtual Screening (1) |
| Viscosity (1) | visible Spectrophotometry (1) | visible spectroscopy (1) |
| Visual analogue scale. (1) | Vitamin D (3) | Vitamin D deficiency (1) |
| Vitamin D. (1) | vitamin E (1) | vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) |
| Vitamin. (1) | Vitex agnus Castus (1) | Vitex negundo (1) |
| Voltage–gated calcium channels (1) | warfarin (2) | Warning signs (1) |
| Water hyacinth (2) | web-based learning (1) | Weibull parameters (1) |
| West timor (1) | Western blot technique (1) | Wet gangrene (2) |
| wet granulation (1) | wetting time (1) | Wheat (1) |
| White/red patch (1) | WHO prescribing indicator (1) | WHO-QOL BREF questionnaire (1) |
| WHO-UMC causality assessment system. (1) | Wilson disease (1) | Wistar rats. (1) |
| Withania somnifera. (1) | Withdrawal (1) | Women. (1) |
| Work protection (1) | Work Satisfaction (1) | World Anti-Doping Agency (1) |
| World Health Organization (1) | Wound Healing (1) | Wound tissue healing (1) |
| Wrightia tinctoria (1) | writhing (1) | X-ray diffraction (1) |
| X-ray imaging study. (1) | X-ray powder diffraction (1) | xanthan gum (1) |
| Xanthangum (1) | XDR-TB (1) | Xenografts (1) |
| Xenografts. (1) | XRD (1) | Ylang-ylang (1) |
| Yoga (1) | Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) |
| Zero order release (1) | zero order spectrophotometry (1) | zeta potential (1) |
| zidovudine (1) | Zika virus (1) | zinc (1) |
| Zinc ion (1) | Zingiber officinale (1) | Zingiberaceae (1) |
| zopiclone (1) | [BMIM]PF6 (1) | Þ rst-order derivative spectroscopy (1) |
| Α-amylase (2) | α-glucosidase (1) | α-mangostin (1) |
| β Amyloid1-42 (1) | β-carboline (1) | β-carotene production (1) |
| β-cyclodextrin (3) | γ-oryzanol (1) | γ-retroviral vector (1) |
| ε-amino groups (1) | | |
